Concurrent FOXP3- And CTLA4-associated genetic predisposition and skewed X chromosome inactivation in an autoimmune disease-prone family

European Journal of Endocrinology

Volumn 167, Issue 1, 2012, Pages 131-134

  Seidel, M G ^a   Rami, B ^b   Item, C ^b   Schober, E ^b   Zeitlhofer, P ^c   Huber, W D ^b   Heitger, A ^d   Bodamer, O A ^e   Haas, O A ^a,c  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^c Medgenat GmbH   (Austria)

^d CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CORTISONE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E; TRANSCRIPTION FACTOR FOXP3;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CD4+ CD25+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CTLA4 GENE; DIARRHEA; ECZEMA; FAILURE TO THRIVE; FEMALE; FOXP3 GENE; GENE MUTATION; GENETIC PREDISPOSITION; GRAVES DISEASE; HASHIMOTO DISEASE; HETEROZYGOSITY; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; MALE; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME INACTIVATION;

ADULT; AUTOIMMUNE DISEASES; CTLA-4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; PEDIGREE; X CHROMOSOME INACTIVATION;

EID: 84862732229     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0197     Document Type: Article

References (17)

1. Vieland VJ, Huang Y, Bartlett C, Davies TF & Tomer Y. A multilocus model of the genetic architecture of autoimmune thyroid disorder, with clinical implications. American Journal of Human Genetics 2008 82 1349-1356. (doi:10.1016/j.ajhg.2008.04.017)
2. Ueda H, Howson J, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow D, Hunter KM, Smith A, Di Genova G, Herr M, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance H, Everett V, Smink L, Lam A, Cordell H, Walker N, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker M, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie K, Undlien DE, Rønningen K, Guja C, Ionescu-Tîrgovişte C, Savage D, Maxwell AP, Carson D, Patterson C, Franklyn J, Clayton D, Peterson L, Wicker L, Todd J & Gough S. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003 423 506-511. (doi:10.1038/nature01621)
3. Gough S, Walker LS & Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunological Reviews 2005 204 102-115. (doi:10.1111/j.0105-2896. 2005.00249.x)
4. Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C, Meschi F, Bonfanti R, Sznajer Y, Tommasini A, Lawitschka A, Junker A, Dunstheimer D, Heidemann PH, Cazzola G, Cipolli M, Friedrich W, Janic D, Azzi N, Richmond E, Vignola S, Barabino A, Chiumello G, Azzari C, Roncarolo MG & Bacchetta R. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. Journal of Allergy and Clinical Immunology 2008 122 1105-1112. (doi:10.1016/j.jaci.2008.09.027)
5. Ziegler S. FOXP3: of mice and men. Annual Review of Immunology 2006 24 209-226. (doi:10.1146/annurev.immunol.24.021605.090547)
6. Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler S, Levings MK & Roncarolo MG. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. Journal of Clinical Investigation 2006 116 1713-1722. (doi:10.1172/JCI25112)
7. Chatila TA. Regulatory T cells: key players in tolerance and autoimmunity. Endocrinology and Metabolism Clinics of North America 2009 38 265-272. (doi:10.1016/j.ecl.2009.01.002)
8. Wildin RS & Freitas A. IPEX and FOXP3: clinical and research perspectives. Journal of Autoimmunity 2005 25 56-62. (doi:10.1016/j.jaut.2005. 04.008)
9. Rubio-Cabezas O, Minton JA, Caswell R, Shield JP, Deiss D, Sumnik Z, Cayssials A, Herr M, Loew A, Lewis V, Ellard S & Hattersley AT. Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care 2009 32 111-116. (doi:10.2337/dc08-1188)
10. Wang C & Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinology and Metabolism Clinics of North America 1997 26 189-218. (doi:10.1016/S0889-8529(05)70240-1)
11. Bizzaro N, Tozzoli R & Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases? Arthritis and Rheumatism 2007 56 1736-1744. (doi:10.1002/art.22708)
12. Brix TH, Knudsen G, Kristiansen M, Kyvik KO, Orstavik KH & Hegedüs L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. Journal of Clinical Endocrinology and Metabolism 2005 90 5949-5953. (doi:10.1210/jc.2005-1366)
13. Ozcelik T, Uz E, Akyerli CB, Bagislar S, Mustafa CA, Gursoy A, Akarsu N, Toruner G, Kamel N & Gullu S. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. European Journal of Human Genetics 2006 14 791-797. (doi:10.1038/sj.ejhg.5201614)
14. Tommasini A, Ferrari S, Moratto D, Badolato R, Boniotto M, Pirulli D, Notarangelo LD & Andolina M. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clinical and Experimental Immunology 2002 130 127-130. (doi:10.1046/j.1365-2249.2002.01940.x)
15. Ozcelik T. X chromosome inactivation and female predisposition to autoimmunity. Clinical Reviews in Allergy & Immunology 2008 34 348-351. (doi:10.1007/s12016-007-8051-0)
16. +CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations. Blood 2009 114 4138-4141. (doi:10.1182/blood-2009-04- 214593)
17. + regulatory T cell function. Science 2008 322 271-275. (doi:10.1126/science.1160062)